Comments
Loading...

Ikena Oncology Analyst Ratings

IKNANASDAQ
Logo brought to you by Benzinga Data
$1.15
At close: May 22 EDT
$1.15
0.000.00%
Pre-Market: 7:20 AM EDT
Consensus Rating1
Buy
Highest Price Target1
$22.00
Lowest Price Target1
$2.00
Consensus Price Target1
$10.25

Ikena Oncology Analyst Ratings and Price Targets | NASDAQ:IKNA | Benzinga

Ikena Oncology Inc has a consensus price target of $10.25 based on the ratings of 4 analysts. The high is $22 issued by HC Wainwright & Co. on March 17, 2023. The low is $2 issued by Wedbush on May 29, 2024. The 3 most-recent analyst ratings were released by HC Wainwright & Co., HC Wainwright & Co., and Wedbush on November 11, 2024, August 12, 2024, and May 29, 2024, respectively. With an average price target of $3.33 between HC Wainwright & Co., HC Wainwright & Co., and Wedbush, there's an implied 189.86% upside for Ikena Oncology Inc from these most-recent analyst ratings.

Analyst Rating and Forecast
12345
3.9
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
Wedbush
Credit Suisse
HC Wainwright & Co.

1calculated from analyst ratings

Analyst Ratings for Ikena Oncology

Buy NowGet Alert
11/11/2024Buy Now247.83%HC Wainwright & Co.
Andres Maldonado43%
$4 → $4ReiteratesBuy → BuyGet Alert
08/12/2024Buy Now247.83%HC Wainwright & Co.
Andres Maldonado43%
$4 → $4ReiteratesBuy → BuyGet Alert
05/29/2024Buy Now73.91%Wedbush
David Nierengarten58%
$8 → $2DowngradeOutperform → NeutralGet Alert
05/29/2024Buy Now247.83%HC Wainwright & Co.
Andres Maldonado43%
$11 → $4MaintainsBuyGet Alert
05/14/2024Buy Now595.65%Wedbush
David Nierengarten58%
$8 → $8ReiteratesOutperform → OutperformGet Alert
03/19/2024Buy Now856.52%HC Wainwright & Co.
Andres Maldonado43%
$11 → $11ReiteratesBuy → BuyGet Alert
03/12/2024Buy Now856.52%HC Wainwright & Co.
Andres Maldonado43%
$11 → $11MaintainsBuyGet Alert
01/19/2024Buy Now595.65%Wedbush
David Nierengarten58%
$8 → $8ReiteratesOutperform → OutperformGet Alert
01/19/2024Buy Now856.52%HC Wainwright & Co.
Andres Maldonado43%
$11 → $11ReiteratesBuy → BuyGet Alert
11/09/2023Buy Now856.52%HC Wainwright & Co.
Andres Maldonado43%
$18 → $11MaintainsBuyGet Alert
09/22/2023Buy Now856.52%Wedbush
David Nierengarten58%
→ $11Initiates → OutperformGet Alert
08/10/2023Buy Now1465.22%HC Wainwright & Co.
Andres Maldonado43%
→ $18ReiteratesBuy → BuyGet Alert
08/07/2023Buy Now1465.22%HC Wainwright & Co.
Andres Maldonado43%
→ $18ReiteratesBuy → BuyGet Alert
05/24/2023Buy Now1465.22%HC Wainwright & Co.
Andres Maldonado43%
→ $18ReiteratesBuy → BuyGet Alert
05/16/2023Buy Now1030.43%Credit Suisse
Judah Frommer65%
→ $13ReiteratesOutperform → OutperformGet Alert
05/04/2023Buy Now1465.22%HC Wainwright & Co.
Andres Maldonado43%
→ $18Assumes → BuyGet Alert
03/17/2023Buy Now1813.04%HC Wainwright & Co.
Robert Burns43%
→ $22Reiterates → BuyGet Alert
03/15/2023Buy Now1030.43%Credit Suisse
Judah Frommer65%
$16 → $13MaintainsOutperformGet Alert
11/29/2022Buy Now1291.3%Credit Suisse
Judah Frommer65%
$18 → $16MaintainsOutperformGet Alert
11/29/2022Buy Now1813.04%HC Wainwright & Co.
Robert Burns43%
$26 → $22MaintainsBuyGet Alert
11/08/2022Buy Now1465.22%Credit Suisse
Judah Frommer65%
$20 → $18MaintainsOutperformGet Alert

FAQ

Q

What is the target price for Ikena Oncology (IKNA) stock?

A

The latest price target for Ikena Oncology (NASDAQ:IKNA) was reported by HC Wainwright & Co. on November 11, 2024. The analyst firm set a price target for $4.00 expecting IKNA to rise to within 12 months (a possible 247.83% upside). 4 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Ikena Oncology (IKNA)?

A

The latest analyst rating for Ikena Oncology (NASDAQ:IKNA) was provided by HC Wainwright & Co., and Ikena Oncology reiterated their buy rating.

Q

When was the last upgrade for Ikena Oncology (IKNA)?

A

There is no last upgrade for Ikena Oncology

Q

When was the last downgrade for Ikena Oncology (IKNA)?

A

The last downgrade for Ikena Oncology Inc happened on May 29, 2024 when Wedbush changed their price target from $8 to $2 for Ikena Oncology Inc.

Q

When is the next analyst rating going to be posted or updated for Ikena Oncology (IKNA)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Ikena Oncology, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Ikena Oncology was filed on November 11, 2024 so you should expect the next rating to be made available sometime around November 11, 2025.

Q

Is the Analyst Rating Ikena Oncology (IKNA) correct?

A

While ratings are subjective and will change, the latest Ikena Oncology (IKNA) rating was a reiterated with a price target of $4.00 to $4.00. The current price Ikena Oncology (IKNA) is trading at is $1.15, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch